The regenerative decade: From SVF and exosomes to biological platforms

The regenerative decade: From SVF and exosomes to biological platforms Torbjörn Ogéus discusses the evolution of regenerative medicine over the past decade, transitioning from a focus on treatments like platelet-rich plasma (PRP) to more integrated biological platforms that address multiple aspects of tissue degeneration. Over the past decade, regenerative medicine has undergone a remarkable transformation. What began as a field focused primarily on platelet-rich plasma (PRP), stromal vascular fraction (SVF), and mesenchymal stem cells (MSCs) has evolved into a rapidly advancing discipline exploring pluripotent cells, extracellular vesicles, biomaterials, tissue engineering, and precision medicine.